Cite

HARVARD Citation

    Prediletto, I. et al. (n.d.). 1423PPre-treatment EGFR-T790M subclones in lung adenocarcinoma harboring activating mutation of EGFR: A positive prognostic factor for survival?. Annals of oncology. p. . [Online]. 
  
Back to record